Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edward F. Kleinman is active.

Publication


Featured researches published by Edward F. Kleinman.


Tetrahedron Letters | 1979

Total synthesis of (±)-Lycodine

Edward F. Kleinman; Clayton H. Heathcock

Abstract (±)-Lycodine ( 1 ) has been synthesized in five steps from cyanoenone 4 . The approach has also been applied to a new synthesis of (±)-lycopodine ( 2 ). Both alkaloids are available in better than 20% overall yield from enone 4 .


Journal of Medicinal Chemistry | 2015

2-Aryl-3-methyloctahydrophenanthrene-2,3,7-triols as Potent Dissociated Glucocorticoid Receptor Agonists

Yves A. Chantigny; John C. Murray; Edward F. Kleinman; Ralph P. Robinson; Michael A. Plotkin; Matthew R. Reese; Leonard Buckbinder; Patricia A. McNiff; Michele L. Millham; Jean Schaefer; Yuriy A. Abramov; Jon Bordner

A significant improvement in agonist activity of the previously described 2-aryloctahydrophenanthrene-2,3,7-triol series of dissociated glucocorticoid receptor agonists (DAGRs) was achieved by modifying the substitution at C3 from (S)-3-hydroxy to (R)-3-hydroxy-3-methyl. The IC50 of the prototype 13 in the efficacy assay measuring repression of IL-1 induced MMP-13 expression was 3.5 nM, exhibiting 87% of the maximal effect of dexamethasone (DEX). It displayed a dissociated profile by exhibiting 42% of the maximal effect of DEX in a mouse mammary tumor virus (MMTV) luciferase reporter transactivation assay. Compound 13 and analogues containing heterocyclic replacements for the C2 phenyl and modified B rings showed high repression of TNFα production in human whole blood, with IC50 values (43-167 nM) approaching the level of DEX (21 nM). On the basis of X-ray structures and force field calculations, the overall potency of this series was attributed to a favorable conformation of the C2α phenyl, induced by the neighboring C3α methyl.


Journal of the American Chemical Society | 1982

Total synthesis of lycopodium alkaloids: (.+-.)-lycopodine, (.+-.)-lycodine, and (.+-.)-lycodoline

Clayton H. Heathcock; Edward F. Kleinman; Edward S. Binkley


Journal of the American Chemical Society | 1978

A highly efficient total synthesis of (.+-.)-lycopodine

Clayton H. Heathcock; Edward F. Kleinman; Edward S. Binkley


Journal of Medicinal Chemistry | 2009

Octahydrophenanthrene-2,7-diol analogues as dissociated glucocorticoid receptor agonists: discovery and lead exploration.

Ralph P. Robinson; Leonard Buckbinder; Amber I. Haugeto; Patricia A. McNiff; Michele L. Millham; Matthew R. Reese; Jean Schaefer; Yuriy A. Abramov; Jon Bordner; Yves A. Chantigny; Edward F. Kleinman; Ellen R. Laird; Bradley Paul Morgan; John C. Murray; Eben Salter; Matthew D. Wessel; Sue A. Yocum


Journal of the American Chemical Society | 1992

Striking example of a contact chloride ion pair with bridging water molecules in the solid state

Edward F. Kleinman; Jon Bordner; Bradley J. Newhouse; Kurtis MacFerrin


ChemInform | 1981

Total synthesis of (.+-.)-lycodoline

Clayton H. Heathcock; Edward F. Kleinman


Archive | 2004

Moduladores del receptor de glucocorticoides

Yves A. Chantigny; Edward F. Kleinman; Jr. Ralph Pelton Robinson


Archive | 2003

Modulateurs du recepteur glucocorticoide

Yves A. Chantigny; Edward F. Kleinman; Jr. Ralph Pelton Robinson


Archive | 1994

Antiinflammatory 3-acyl-2-oxindole-1-carboxamides of pro-drugs

Wayne E. Barth; Kelvin Cooper; Edward F. Kleinman; Lawrence A. Reiter; Ralph P. Robinson

Collaboration


Dive into the Edward F. Kleinman's collaboration.

Researchain Logo
Decentralizing Knowledge